Jim Simons’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,300
Closed -$959K 3593
2025
Q4
$959K Sell
9,300
-2,700
-23% -$263K ﹤0.01% 2305
2025
Q3
$1.08M Sell
12,000
-2,400
-17% -$210K ﹤0.01% 2442
2025
Q2
$1.27M Buy
+14,400
New +$1.25M ﹤0.01% 2379
2024
Q4
Sell
-19,400
Closed -$1.84M 3834
2024
Q3
$1.84M Sell
19,400
-6,500
-25% -$617K ﹤0.01% 2074
2024
Q2
$2.37M Buy
25,900
+11,902
+85% +$1.06M ﹤0.01% 1773
2024
Q1
$1.27M Sell
13,998
-5,602
-29% -$490K ﹤0.01% 2329
2023
Q4
$1.59M Buy
19,600
+10,400
+113% +$815K ﹤0.01% 2089
2023
Q3
$735K Buy
9,200
+4,600
+100% +$371K ﹤0.01% 2505
2023
Q2
$362K Sell
4,600
-2,500
-35% -$196K ﹤0.01% 3042
2023
Q1
$551K Buy
+7,100
New +$547K ﹤0.01% 2833
2019
Q2
Sell
-4,800
Closed -$291K 3716
2019
Q1
$291K Buy
4,800
+800
+20% +$47.3K ﹤0.01% 3104
2018
Q4
$219K Buy
+4,000
New +$242K ﹤0.01% 3111

Other funds holding PPH

Jim Simons's PPH Position: Q1 2026 in Review

Jim Simons sold out of VanEck Pharmaceutical ETF (PPH) in Q1 2026, closing a stake of 9,300 shares — an estimated $959K sold.

Jim Simons first reported a position in PPH in Q4 2018 and held it in 12 quarters. The position peaked at $2.37M in Q2 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Jim Simons reported no remaining VanEck Pharmaceutical ETF position as of Q1 2026 after selling out during the quarter.
  • Jim Simons sold 9,300 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $959K.
  • Jim Simons first reported a position in VanEck Pharmaceutical ETF in Q4 2018 and held it in 12 quarters.
  • Jim Simons's VanEck Pharmaceutical ETF position peaked at $2.37M in Q2 2024.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.